Celltrion to develop oral autoimmune disease treatment with US firm
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
South Korea is planning to nurture the biotechnology industry as a new economic growth engine. Choo Kyung-ho, Korea’s Finance Minister, ...
On Monday, South Korea's Ministry of Small and Medium-sized Enterprises (SMEs) and Startups announced the 'Global Innovation Special Zone Creation ...
South Korean In Vitro Diagnostics (IVD) medical device, and diagnostic reagent developer, AMSBIO is looking forward to building a new ...
South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) ...
SK Holdings on Monday said that it injected 8 billion won ($6.5 million) in Hummingbird Bioscience to secure novel antibody-based ...
LegoChem Biosciences Inc. announced it signed a 496.3 billion won ($405 million) worth agreement on licensing out its antibody-drug conjugate ...
Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...
Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |
Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |